Orthopedics News Alerts

 
 
  • Alert PharMEDium Recalls Compounded Bupivacaine Products The nationwide recall involves hundreds of sterile preparations compounded with a single recalled lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl).
  • Alert FDA Proposes Ban of Powdered Medical Gloves A ban of powdered gloves for surgery and patient exams would not create a glove shortage, given the ascendancy of powderless alternatives, the agency said.
  • Alert DPP-4 Inhibitors Can Cause Severe Joint Pain, FDA Says However, the pain associated with dipeptidyl peptidase-4 inhibitors for type 2 diabetes goes away once patients stop taking the medicine, according to the agency.
  • Alert FDA to Study Safety, Effectiveness of Healthcare Antiseptics The agency urges clinicians to keep using the antiseptic products in question for the sake of infection control, even as it looks at the possible effects of daily, long-term use.
  • Alert HHS Secretary Kathleen Sebelius Resigns Kathleen Sebelius, the health and human services secretary, is resigning, ending her 5-year term that was marred by the problem-plagued rollout of the Affordable Care Act.
  • Alert House Passes Budget Deal With 3-Month 'Doc Fix' The bill, which awaits a Senate vote, preserves the 2% sequestration cut to Medicare pay. Meanwhile, legislation repealing the program's SGR formula made progress in both the House and Senate.
  • Alert Acetaminophen Poses Risk for Rare but Fatal Skin Reactions The FDA today warned that anyone who takes the painkiller and develops a skin rash or reaction should discontinue using the drug and seek medical attention immediately.
  • Alert Another Pharmacy Linked to Potentially Contaminated Steroids The FDA is investigating 7 adverse reactions, including at least 1 infection that may be fungal in nature, associated with steroid shots compounded at Main Street Family Pharmacy in Tennessee.
  • Alert Another Compounding Company Recalls All Sterile Product Balanced Solutions Compounding Pharmacy has voluntarily recalled all lots of its sterile drug products because of sterility concerns, the FDA says.
  • Alert Strontium Ranelate Restrictions Recommended in EU An EU regulatory committee has recommended restricting the use of the osteoporosis drug strontium ranelate (Protelos/Osseor) to reduce the risk for adverse cardiac events in postmenopausal women.
  • Alert More Adverse Events Reported for Surgical Waste System The recalled Stryker devices, still in use by facilities lacking an alternative, can damage soft tissue, muscle, and vital organs when improperly used. The FDA has received reports of injuries and deaths.
  • Alert Hyalograft C Autograft Coming Off European Market Anika Therapeutics has withdrawn centralized marketing authorization application for Hyalograft C autograft.
  • Alert FDA Recalls J&J's Orthopedic Device The U.S. Food and Drug Administration said it has notified healthcare professionals of a Class I recall, the most serious type, of an orthopedic device made by Johnson & Johnson.
  • Alert State of the Union Addresses Medicare Reform, Gun Control The president also said he is willing to pare Medicare costs with reforms such as pay-for-performance, but added that he will not make seniors shoulder an unfair burden of deficit reduction.
  • Alert Metal-on-Metal Hip Implants: Use With Caution, FDA Says The agency released extensive guidelines today for problematic, all-metal hip implants that range from selecting the right surgical candidate to determining when to replace the hardware.
  • Alert 32-Mg IV Zofran Pulled From Market This particular dose of the antinausea drug can lead to a deadly heart rhythm, says the FDA, which expects voluntary recalls of generic versions as well.
  • Alert CDC on Fungal Meningitis: Consider LP in Asymptomatic Patients Ongoing investigation pinpoints patients at greatest risk, sees 'significant' violations at NECC; FDA posts detailed NECC customer lists.
  • Alert Romney, Obama Hammer Each Other on Medicare in Debate Romney pounded away on $716 billion in Medicare cuts enacted by the ACA, while Obama said his opponent's premium support plan would leave seniors 'at the mercy of insurance companies.'
  • Alert FDA Warns of Burns From Topical Pain Relievers The US Food and Drug Administration warns of the potential for burns with over-the-counter topical joint and muscle pain relievers.
  • Alert Calcitonin Linked to Cancer Risk, EMA Warns The European version of the FDA is recommending market withdrawal of calcitonin nasal spray, used to treat osteoporosis. Two brand-name versions are marketed in the United States.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.